热门资讯> 正文
Aptose Biosciences Q3 EPS $(2.01) Misses $(1.95) Estimate
2025-11-14 06:21
Aptose Biosciences (TSX: APS) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.95) by 3.08 percent. This is a 81.89 percent increase over losses of $(11.10) per share from the same period last year.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
